Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Implexion Pharma AB
AB
Active
Org 5592026297
Erik Dahlbergsgatan 11, 411 26
Göteborg
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2019
0 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Implexion Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
-1M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
0
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
−26
−61
−219
−592
−340
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−26
−61
−219
−592
−340
Net financials
—
—
—
8
−14
Profit before tax
−26
−61
−219
−585
−354
Tax
−0
−0
−0
−0
−0
Net profit
−26
−61
−219
−585
−354
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
695
594
1 489
1 020
1 109
Equity
397
336
1 116
531
177
Long-term debt
0
0
40
280
460
Short-term debt
298
258
334
209
472
Total debt
298
258
374
489
932
Financial ratios
5-year trend
EBITDA-margin
-34000000.0%
This company
15.8%
Market median
-215189973% vs market
2020
2024
Soliditetsgrad
16.0%
This company
38.2%
Market median
-58% vs market
2020
2024
Egenkapitalforrentning
-200.0%
This company
18.4%
Market median
-1187% vs market
2020
2024
Nettoresultatgrad
-35400000.0%
This company
8.1%
Market median
-437037137% vs market
2020
2024
Aktivomsætning
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Gæld/egenkapital
5.27×
This company
0.62×
Market median
-750% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Implexion Pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
